The Trump administration is reportedly revisiting policies aimed at closing a loophole in Medicare drug price negotiations.
This action comes amid ongoing discussions about the effectiveness of current drug pricing strategies within the Medicare program.
While specific details of the measures have not been disclosed, the administration's intent to address this issue has been confirmed.
Updates
Update at 21:45 UTC on 2026-06-12
STAT reported Trump administration revisits policy to plug Medicare drug price negotiation loophole.
Sources: STAT